Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An important consideration when studying factors that influence drinking/relapse is influence of the pharmacological effects of alcohol on these behaviors. Pre-exposure to alcohol (priming) can increase craving, drinking and seeking behaviors
BACKGROUND: Our laboratory has previously shown that the smoking-cessation agent varenicline, an ago...
AbstractThe pharmacotherapy currently used for alcohol dependence may reduce alcohol consumption and...
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combinat...
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An importan...
Rationale: Treatment of the most widely abused drugs, nicotine and alcohol, is hampered by high rate...
Background Varenicline, a partial agonist at α4β2 and full agonist at α7 nicotinic cholinergic rece...
Rationale \ud Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor...
Abstract Alcohol dependence is a disease that impacts millions of individuals worldwide. There has b...
Background Most alcoholics experience periods of voluntary alcohol abstinence or imposed alcohol ...
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline all...
Background: Preclinical and emerging clinical evidence indicates that varenicline, a nicotinic parti...
Artículo de publicación ISIRationale Neuronal nicotinic acetylcholine receptors (nAChRs) are pharma...
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit ...
Background: Alcohol and nicotine are largely co-abused. Here, we investigated whether concurrent exp...
Alcohol and nicotine use disorders are often treated as separate diseases, despite evidence that app...
BACKGROUND: Our laboratory has previously shown that the smoking-cessation agent varenicline, an ago...
AbstractThe pharmacotherapy currently used for alcohol dependence may reduce alcohol consumption and...
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combinat...
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An importan...
Rationale: Treatment of the most widely abused drugs, nicotine and alcohol, is hampered by high rate...
Background Varenicline, a partial agonist at α4β2 and full agonist at α7 nicotinic cholinergic rece...
Rationale \ud Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor...
Abstract Alcohol dependence is a disease that impacts millions of individuals worldwide. There has b...
Background Most alcoholics experience periods of voluntary alcohol abstinence or imposed alcohol ...
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline all...
Background: Preclinical and emerging clinical evidence indicates that varenicline, a nicotinic parti...
Artículo de publicación ISIRationale Neuronal nicotinic acetylcholine receptors (nAChRs) are pharma...
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit ...
Background: Alcohol and nicotine are largely co-abused. Here, we investigated whether concurrent exp...
Alcohol and nicotine use disorders are often treated as separate diseases, despite evidence that app...
BACKGROUND: Our laboratory has previously shown that the smoking-cessation agent varenicline, an ago...
AbstractThe pharmacotherapy currently used for alcohol dependence may reduce alcohol consumption and...
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combinat...